Appliedclinicaltrialsonline
Published October 6, 2026
ACT Brief: Ibogaine Trial Design Guidance, Outsourcing Model Oversight Gaps, and Kidney ...
Read the full story at Appliedclinicaltrialsonline
In today's ACT Brief, we examine FDA input sought on early-phase ibogaine protocols, why mixed outsourcing models spread faster than oversight.
Surfaced by this Google Alert
- Ibogaine
